Lever Bio

2 known investors

Lever Bio is an immuno-oncology company developing compounds that reprogram the solid tumor microenvironment to enhance the recruitment, activation, and function of cytotoxic T lymphocytes against solid tumors. It works with researchers, universities, and research centers to advance cancer immunotherapy drug development.